Literature DB >> 24858336

Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular Dystrophy.

Shipeng Yu1, Ahmed Abdelkarim, Ali Nawras, Bryan Thomas Hinch, Chimaka Mbaso, Shahul Valavoor, Fadi Safi, Jeffrey Hammersley, Jianlin Tang, Ragheb Assaly.   

Abstract

Clostridium difficile (C diff) colitis infection is the most common cause of nosocomial infectious diarrhea and the prevalence is increasing worldwide. Toxic megacolon is a severe complication of C diff colitis associated with high mortality. Gastrointestinal (GI) comorbidity and impaired smooth muscle contraction are risk factors for the development of C diff-associated toxic megacolon. We present a case of fulminant C diff colitis with toxic megacolon in a patient with Duchenne muscular dystrophy (DMD) in the intensive care unit. C diff colitis was diagnosed by clinical presentation and positive C diff DNA amplification test (polymerase chain reaction). The impairment of GI tract due to DMD predisposes these patients to severe C diff infection and toxic megacolon, as observed in this case report. For the same reason, the recovery of GI function in these patients can be prolonged. While surgery was conducted for relieving the pressure from toxic megacolon, fecal microbiota transplantation through colonoscopy resulted in successful resolution of the C diff symptoms, although the recovery is prolonged due to DMD.

Entities:  

Mesh:

Year:  2016        PMID: 24858336     DOI: 10.1097/MJT.0000000000000062

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  6 in total

1.  Fecal Microbiota Transplant for Clostridium difficile Colitis-Induced Toxic Megacolon.

Authors:  S P Costello; A Chung; J M Andrews; R J Fraser
Journal:  Am J Gastroenterol       Date:  2015-05       Impact factor: 10.864

2.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

3.  Intestinal microbiota as modulators of the immune system.

Authors:  Borja Sánchez; Miguel Gueimonde; Amado Salvador Peña; David Bernardo
Journal:  J Immunol Res       Date:  2015-03-02       Impact factor: 4.818

Review 4.  Fecal Microbial Transplantation in Critically Ill Patients-Structured Review and Perspectives.

Authors:  Ivana Cibulková; Veronika Řehořová; Jan Hajer; František Duška
Journal:  Biomolecules       Date:  2021-10-04

Review 5.  Role of Fecal Microbiota Transplantation in Reducing Clostridioides difficile Infection-Associated Morbidity and Mortality: A Systematic Review.

Authors:  Adarsh Srinivas Ramesh; Carlos Munoz Tello; Dawood Jamil; Hadrian Hoang-Vu Tran; Mafaz Mansoor; Samia Rauf Butt; Travis Satnarine; Pranuthi Ratna; Aditi Sarker; Safeera Khan
Journal:  Cureus       Date:  2022-08-25

Review 6.  Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015.

Authors:  Joana Carmo; Susana Marques; Iolanda Chapim; Maria Ana Túlio; José Pedro Rodrigues; Miguel Bispo; Cristina Chagas
Journal:  GE Port J Gastroenterol       Date:  2015-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.